Smartkarma's AI Co-Pilot, Smartkarma

αSK

Smartkarma's AI Co-Pilot

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
  <li>
<a href="https://smartkarma.com/entities/eoflow-co-ltd">Eoflow</a> is a high-risk, pre-profitable medical device company whose primary product, the EOPatch wearable insulin pump, faces intense competition and significant legal challenges that threaten its viability.</li>
  <li>The company's financial performance is characterized by substantial and consistent net losses, negative margins, and negative cash flow, with its ability to continue as a going concern clouded by a major patent infringement lawsuit.</li>
  <li>A planned acquisition by Medtronic, which would have provided a crucial global distribution network and financial stability, was terminated in late 2023, leaving <a href="https://smartkarma.com/entities/eoflow-co-ltd">Eoflow</a> in a precarious strategic position.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  
Eoflow is a high-risk, pre-profitable medical device company whose primary product, the EOPatch wearable insulin pump, faces intense competition and significant legal challenges that threaten its viability.
  The company's financial performance is characterized by substantial and consistent net losses, negative margins, and negative cash flow, with its ability to continue as a going concern clouded by a major patent infringement lawsuit.
  A planned acquisition by Medtronic, which would have provided a crucial global distribution network and financial stability, was terminated in late 2023, leaving Eoflow in a precarious strategic position.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

South Korea

Eoflow Co.,Ltd. develops and sells medical devices. The Company produces and sells wearable disposable insulin pumps and other products. Eoflow markets its products throughout Korea.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Eoflow (294090 KS)

Primer: Eoflow (294090 KS) - Apr 2026

Eoflow is a high-risk, pre-profitable medical device company whose primary product, the EOPatch wearable insulin pump, faces intense...

αSK

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)